FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new agent possessing antidiabetic action. The agent represents an oxovanadium (IV) complex in dimethyl sulphoxide (DMSO) of formula VO(DMSO)5·(ClO4)2 - pentakis (dimethyl sulphoxide) oxovanadium (IV) perchlorate. What is also presented is a method for producing the oxovanadium (IV) complex in dimethyl sulphoxide.
EFFECT: invention can be used in the integrated treatment of type two diabetes mellitus.
2 cl, 2 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT BASED ON OXOVANADIUM DERIVATIVE AND METHOD FOR IT PREPARING | 2001 |
|
RU2203656C1 |
OXOVANADIUM COMPLEXES OF L-MALIC ACID SHOWING HYPOGLYCEMIC ACTIVITY | 1996 |
|
RU2101287C1 |
OXOVANADIUM COMPLEX WITH GLYCINE MANIFESTING HYPOGLYCEMIC ACTIVITY | 2007 |
|
RU2341528C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
NOVEL VANADIUM DERIVATIVES HAVING HYPOGLYCEMIC ACTIVITY | 2019 |
|
RU2709491C1 |
BIOLOGICALLY ACTIVE NUTRITIVE SUPPLEMENT WITH INSULIN-LIKE EFFECT BASED ON BIS-(L-MALATO)-OXOVANADIUM (IV) | 2000 |
|
RU2191018C2 |
MEDICATION FOR PREVENTION AND CORRECTION OF DIABETES MANIFESTATIONS | 2012 |
|
RU2563234C2 |
METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
DRUG FOR PREVENTION AND TREATMENT OF DIABETES | 2013 |
|
RU2597848C2 |
COMPOSITION POSSESSING ANTIDIABETIC ACTION | 2015 |
|
RU2611353C2 |
Authors
Dates
2015-08-20—Published
2014-09-10—Filed